This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Morrisons 2018 like-for-like sales ex-fuel/VAT +4.8% (Retail +1.5%, W’sale +3.3%); Q4/H2 slowed vs Q3/H1; adj. pre-tax profit +8.6% (statutory -15.8%), adj. free-cash flow +17.5% (statutory -24%); net pension surplus +15.8%; final div +7.2%, repeats 4p special; £700m wholesale target hit early. On-track for incremental profit target from wholesale/services/interest/online; net debt to stay low.
Hikma Pharma 2018 revenues +7%, core EBITDA +17%, core operating profit +19%, net debt -33.8%. Final div +13% (FY: +11.7%). Sees FY’19 Injectables revenues +2-8%, FX Branded constant growth mid-single digits, Generics +1% to -6% after price erosion.
Standard Life Aberdeen 2018 adj. pre-tax profit for continuing operations -1.5%; but gross inflows +3.9%, but net outflows +24.3% with Assets Under Mgt -9.3%. Final div unchanged. Ahead on cost efficiencies. Challenging market conditions
Dixons Carphone fined £29.1m by FCA over 2008-2015 Geek Squad mobile phone insurance selling. Accepts the short-falls, received discount for early settlement. FY guidance unchanged.
Provident Financial FY rev. flat, books £241.6m impairment for IFRS9 accounting. Adj. pre-tax profit +82.3%, reinstates div (10p/share). Trading in-line. Vanquis refund programme 99% complete and Moneybarn made progress with FCA to address issues. New Vanquis MD to join in April.
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| CAIRN ENERGY | CNE | -14.5% | -12.4% | -16.9% |
| SIRIUS MINERALS | SXX | -2.1% | -0.1% | -6.1% |
| DOMINO’S PIZZA | DOM | 0.0% | 6.7% | -4.6% |
| 888 | 888 | 1.7% | 5.7% | -1.5% |
| G4S | GFS | 1.4% | 2.9% | -4.7% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research